News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
881,881 Results
Type
Article (88672)
Company Profile (816)
Press Release (792364)
Multimedia
Podcasts (232)
Webinars (35)
Section
Business (233545)
Career Advice (4159)
Deals (39962)
Drug Delivery (175)
Drug Development (91653)
Employer Resources (207)
FDA (18538)
Job Trends (17477)
News (398620)
Policy (40012)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (3047)
Academic (2)
Accelerated approval (52)
Adcomms (40)
Allergies (186)
Alliances (56987)
ALS (227)
Alzheimer's disease (1952)
Antibody-drug conjugate (ADC) (521)
Approvals (18852)
Artificial intelligence (835)
Autoimmune disease (329)
Automation (61)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (242)
Biotechnology (480)
Bladder cancer (209)
Brain cancer (83)
Breast cancer (810)
Cancer (6295)
Cardiovascular disease (539)
Career advice (3593)
Career pathing (50)
CAR-T (368)
CDC (75)
Celiac Disease (3)
Cell therapy (1036)
Cervical cancer (49)
Clinical research (78619)
Collaboration (2290)
Company closure (8)
Compensation (1460)
Complete response letters (103)
COVID-19 (3033)
CRISPR (120)
C-suite (1231)
Cystic fibrosis (164)
Data (8265)
Decentralized trials (3)
Denatured (88)
Depression (188)
Dermatology (92)
Diabetes (638)
Diagnostics (7532)
Digital health (62)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (406)
Drug pricing (245)
Drug shortages (39)
Duchenne muscular dystrophy (309)
Earnings (102442)
Editorial (77)
Employer branding (25)
Employer resources (174)
Events (137934)
Executive appointments (1170)
FDA (22482)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (36)
Funding (1878)
Gene editing (264)
Generative AI (87)
Gene therapy (838)
GLP-1 (1256)
Government (5547)
Grass and pollen (8)
Guidances (413)
Healthcare (21127)
HIV (90)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (102)
Immunology and inflammation (350)
Immuno-oncology (106)
Indications (197)
Infectious disease (3415)
Inflammatory bowel disease (240)
Inflation Reduction Act (17)
Influenza (147)
Intellectual property (304)
Interviews (820)
IPO (17994)
IRA (61)
Job creations (5206)
Job search strategy (2871)
JPM (73)
Kidney cancer (22)
Labor market (115)
Layoffs (682)
Leadership (51)
Legal (10171)
Liver cancer (108)
Longevity (35)
Lung cancer (825)
Lymphoma (443)
Machine learning (65)
Management (66)
Manufacturing (1174)
MASH (211)
Medical device (15249)
Medtech (15384)
Mergers & acquisitions (23241)
Metabolic disorders (1715)
mRNA (256)
Multiple sclerosis (199)
NASH (24)
Neurodegenerative disease (483)
Neuropsychiatric disorders (125)
Neuroscience (3627)
Neurotech (2)
NextGen: Class of 2026 (7713)
Non-profit (5139)
Now hiring (79)
Obesity (831)
Opinion (369)
Ovarian cancer (235)
Pain (281)
Pancreatic cancer (326)
Parkinson's disease (397)
Partnered (39)
Patents (633)
Patient recruitment (712)
Peanut (67)
People (67836)
Pharmaceutical (136)
Pharmacy benefit managers (36)
Phase 1 (24291)
Phase 2 (34155)
Phase 3 (25677)
Pipeline (9193)
Policy (391)
Postmarket research (3559)
Preclinical (10943)
Press Release (72)
Prostate cancer (327)
Psychedelics (68)
Radiopharmaceuticals (358)
Rare diseases (1218)
Real estate (7461)
Recruiting (81)
Regulatory (30193)
Reports (77)
Research institute (2764)
Resumes & cover letters (653)
Rett syndrome (40)
RNA editing (28)
RSV (98)
Schizophrenia (193)
Series A (316)
Series B (229)
Service/supplier (28)
Sickle cell disease (122)
Special edition (32)
Spinal muscular atrophy (189)
Sponsored (55)
Startups (4367)
State (2)
Stomach cancer (21)
Supply chain (141)
Tariffs (104)
The Weekly (141)
Vaccines (1276)
Venture capital (126)
Weight loss (572)
Women's health (136)
Worklife (24)
Date
Today (12)
Last 7 days (565)
Last 30 days (3518)
Last 365 days (32949)
2026 (14232)
2025 (33225)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58721)
2020 (57664)
2019 (51336)
2018 (39119)
2017 (37189)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1296)
Alabama (102)
Alaska (7)
Arizona (393)
Arkansas (16)
Asia (52147)
Australia (9172)
California (13991)
Canada (3926)
China (1481)
Colorado (599)
Connecticut (616)
Delaware (431)
Europe (120263)
Florida (2075)
Georgia (457)
Hawaii (4)
Idaho (69)
Illinois (1189)
India (99)
Indiana (646)
Iowa (25)
Japan (563)
Kansas (142)
Kentucky (56)
Louisiana (48)
Maine (89)
Maryland (1700)
Massachusetts (10204)
Michigan (417)
Minnesota (781)
Mississippi (7)
Missouri (162)
Montana (37)
Nebraska (30)
Nevada (150)
New Hampshire (92)
New Jersey (3712)
New Mexico (34)
New York (3665)
North Carolina (1892)
North Dakota (11)
Northern California (6925)
Ohio (433)
Oklahoma (26)
Oregon (55)
Pennsylvania (2775)
Puerto Rico (30)
Rhode Island (53)
South America (1668)
South Carolina (88)
South Dakota (2)
Southern California (5477)
Tennessee (222)
Texas (2271)
United States (50044)
Utah (418)
Vermont (1)
Virginia (356)
Washington D.C. (88)
Washington State (1147)
West Virginia (4)
Wisconsin (155)
Wyoming (2)
There are 881,881 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cancer
All eyes on Revolution, bispecific antibodies and more at ASCO26
Partners Summit Therapeutics and Akeso are expected to steal the show at the American Society of Clinical Oncology’s annual conference with data from their potential Keytruda rival, alongside Revolution Medicine’s groundbreaking pancreatic cancer candidate and other assets that could reshape patient care.
May 26, 2026
·
6 min read
·
Brianna Abbott
Drug Development
4 troubled targets that have thwarted biopharma
The tragic tale of TIGIT is well known. However, RIPK1, myc, STING and alpha-synuclein have also left a trail of failed clinical trials, canceled partnerships and sunk investments in their wake.
May 26, 2026
·
9 min read
·
Tristan Manalac
Duchenne muscular dystrophy
REGENXBIO, Novartis, Dyne near FDA submissions in muscular dystrophies
Analysts homed in on Duchenne muscular dystrophy and myotonic dystrophy type 1 assets during first quarter earnings as major players like REGENXBIO and Novartis as well as Dyne, Wave, Solid and Sarepta near the regulatory finish line.
May 26, 2026
·
9 min read
·
Heather McKenzie
Press Releases
A single dose of Lilly’s PCSK9 base editor, VERVE-102, reduced PCSK9 by up to 88% and LDL-C by up to 62%, with durable effects supporting its potential as a one-time treatment for hypercholesterolemia
May 25, 2026
·
8 min read
Press Releases
LSL PHARMA GROUP REPORTS RECORD REVENUES AND FIRST QUARTER 2026 RESULTS
May 25, 2026
·
12 min read
Press Releases
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease
May 25, 2026
·
4 min read
Press Releases
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - May 22, 2026
May 25, 2026
·
3 min read
Press Releases
Immix Biopharma Announces Closing of $150 Million Underwritten Offering of Common Stock
May 25, 2026
·
2 min read
Press Releases
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2026
May 25, 2026
·
1 min read
Press Releases
Avalo Therapeutics Announces Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) - May 22, 2026
May 25, 2026
·
3 min read
1 of 88,189
Next
